Skip to main content
. 2025 Jul 5;25:494. doi: 10.1186/s12872-025-04953-9

Table 4.

Analysis of In-hospital outcomes in VA patients (VT/VF vs. Non-VT/VF)

All (n = 359) VT/VF (n = 95) Non-VT/VF (n = 264) P value
In-hospital MACE, n (%) 54 (15.0%) 24 (25.3%) 30 (11.4%) < 0.001
Cardiac death, n (%) 14 (3.9%) 8 (8.4%) 6 (2.3%) 0.012
MI, n (%) 48 (13.4%) 22 (23.2%) 26 (9.8%) 0.002
TVR, n (%) 33 (9.2%) 14 (14.7%) 19 (7.2%) 0.029
Acute stent thrombosis, n (%) 3 (0.8%) 1 (1.1%) 2 (0.8%) 0.763

Categorical variables were expressed as number (percentage)

VA Ventricular arrhythmia, VT Ventricular tachycardia, VF Ventricular fibrillation, MACE Major adverse cardiovascular event, TVR Target-vessel revascularization, MI Myocardial infarction